Integrative omics analyses broaden treatment targets in human cancer

被引:0
|
作者
Sohini Sengupta
Sam Q. Sun
Kuan-lin Huang
Clara Oh
Matthew H. Bailey
Rajees Varghese
Matthew A. Wyczalkowski
Jie Ning
Piyush Tripathi
Joshua F. McMichael
Kimberly J. Johnson
Cyriac Kandoth
John Welch
Cynthia Ma
Michael C. Wendl
Samuel H. Payne
David Fenyö
Reid R. Townsend
John F. Dipersio
Feng Chen
Li Ding
机构
[1] Washington University,Division of Oncology, Department of Medicine
[2] Washington University,McDonnell Genome Institute
[3] Washington University,Division of Nephrology, Department of Medicine
[4] Brown School,Department of Mathematics
[5] Washington University,Department of Genetics
[6] Marie-Josée and Henry R. Kravis Center for Molecular Oncology,Biological Sciences Division
[7] Memorial Sloan Kettering Cancer Center,Department of Biochemistry and Molecular Pharmacology
[8] Washington University,Institute for Systems Genetics
[9] Washington University,Siteman Cancer Center
[10] Pacific Northwest National Laboratory,undefined
[11] New York University Langone School of Medicine,undefined
[12] New York University Langone School of Medicine,undefined
[13] Washington University,undefined
来源
关键词
Cancer genomics; Multi-omics; Proteogenomics; Precision medicine; Cancer and druggability;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Integrative omics analyses broaden treatment targets in human cancer
    Sengupta, Sohini
    Sun, Sam Q.
    Huang, Kuan-lin
    Oh, Clara
    Bailey, Matthew H.
    Varghese, Rajees
    Wyczalkowski, Matthew A.
    Ning, Jie
    Tripathi, Piyush
    McMichael, Joshua F.
    Johnson, Kimberly J.
    Kandoth, Cyriac
    Welch, John
    Ma, Cynthia
    Wendl, Michael C.
    Payne, Samuel H.
    Fenyo, David
    Townsend, Reid R.
    Dipersio, John F.
    Chen, Feng
    Ding, Li
    GENOME MEDICINE, 2018, 10
  • [2] Integrative omics analyses uncover the mechanism underlying the immunotoxicity of perfluorooctanesulfonate in human lymphocytes
    Li, Rong
    Guo, Chao
    Lin, Xiao
    Chan, Ting Fung
    Lai, Keng Po
    Chen, Jian
    CHEMOSPHERE, 2020, 256
  • [3] The Cancer Omics Atlas: an integrative resource for cancer omics annotations
    Qingrong Sun
    Mengyuan Li
    Xiaosheng Wang
    BMC Medical Genomics, 11
  • [4] Cellomics as Integrative Omics for Cancer
    Boda, Daniel
    CURRENT PROTEOMICS, 2013, 10 (03) : 237 - 245
  • [5] The Cancer Omics Atlas: an integrative resource for cancer omics annotations
    Sun, Qingrong
    Li, Mengyuan
    Wang, Xiaosheng
    BMC MEDICAL GENOMICS, 2018, 11
  • [6] Identifying Actionable Targets through Integrative Analyses of GEM Model and Human Prostate Cancer Genomic Profiling
    Wanjala, Jackie
    Taylor, Barry S.
    Chapinski, Caren
    Hieronymus, Haley
    Wongvipat, John
    Chen, Yu
    Nanjangud, Gouri J.
    Schultz, Nikolaus
    Xie, Yingqiu
    Liu, Shenji
    Lu, Wenfu
    Yang, Qing
    Sander, Chris
    Chen, Zhenbang
    Sawyers, Charles L.
    Carver, Brett S.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (01) : 278 - 288
  • [7] INTEGRATIVE OMICS BASED NEXT-GENERATION MOLECULAR MARKERS AND TARGETS IN COLORECTAL CANCER
    Barh, D.
    Bhat, D.
    ANNALS OF ONCOLOGY, 2010, 21 : 70 - 71
  • [8] Correction to: The Cancer Omics Atlas: an integrative resource for cancer omics annotations
    Qingrong Sun
    Mengyuan Li
    Xiaosheng Wang
    BMC Medical Genomics, 11
  • [9] Integrative -omics analysis to identify drug targets for ccRCC immunotherapy
    Reustle, Anna
    Di Marco, Moreno
    Buettner, Florian
    Winter, Stefan
    Kandabarau, Siarhei
    Kowalewski, Daniel
    Backert, Linus
    Rausch, Steffen
    Hennenlotter, Joerg
    Scharpf, Marcus
    Fend, Falko
    Stenzl, Arnulf
    Bedke, Jens
    Stevanovic, Stefan
    Schwab, Matthias
    Schaeffeler, Elke
    CANCER RESEARCH, 2018, 78 (13)
  • [10] Analyses that combine 'omics' show cell targets in detail
    Shraddha Chakradhar
    Nature Medicine, 2015, 21 : 965 - 966